MedPath

Personalized Tidal Volume in ARDS (VT4HEMOD)

Not Applicable
Recruiting
Conditions
Acute Respiratory Distress Syndrome
Interventions
Procedure: Standardized ventilation
Procedure: Personalized ventilation
Registration Number
NCT05406570
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Treatment of acute respiratory distress syndrome (ARDS) relies on invasive mechanical ventilation with supposedly protective settings (low tidal volume ventilation). Mortality of ARDS remains high in observational studies (40 to 50%). Approximately 30% of ARDS patients exhibit tidal hyperinflation despite low tidal volume ventilation, suggesting that personalization of tidal volume is required to improve ARDS prognostic. To date, reliable bedside tools to adjust tidal volume are lacking. Excessive tidal volume can be detected using computed tomography by quantification of tidal hyperinflation, but this technique is reserved to research studies and requires patient transport to imaging facility.

Mechanical ventilation generates cardio-pulmonary interaction, whose magnitude is influenced by tidal volume and respiratory system characteristics. Pulse pressure variation is a bedside tool with potential to quantify cardio-pulmonary interactions. Increasing tidal volume will decrease right ventricular preload and increase right ventricular afterload, hence maximizing cardio-pulmonary interactions.

The investigators hypothesize that pulse pressure variation might help to detect excessive tidal volume during a tidal volume challenge (i.e. stepwise increase in tidal volume)

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Age greater then 18 years old
  2. ARDS according to the BERLIN definition with PaO2/FiO2 ratio ≤ 150 mm Hg
  3. invasive mechanical ventilation in volume controlled mode with tidal volume set to 6 ml/kg predicted body weight
  4. use of sedation and neuromuscular-blocking agents
  5. arterial catheter allowing computation of pulse contour cardiac output calibrated with thermodilution
  6. central venous catheter implanted in the superior vena cava territory
  7. esophageal balloon
  8. Computed tomography planned by attending physician
Read More
Exclusion Criteria
  1. Previous inclusion in current study
  2. Acute cor pulmonale
  3. ECMO
  4. Arterial pH < 7.21 despite respiratory rate set to a maximum of 35/min
  5. Pneumothorax or bronchopleural fistula
  6. Decision to withdraw or withhold life sustaining treatment with 24 hours from inclusion
  7. Contra-indication of transport to imaging facility
  8. Intracranial hypertension
  9. Tricuspid or pulmonary mechanical valve
  10. Tricuspid or pulmonary infective endocarditis
  11. Pace maker with intracardiac leads
  12. Right ventricle tumor
  13. Complete left bundle block
  14. Intrathoracic metallic device
  15. COPD
  16. Cardiac arrythmia
  17. Vesical pressure > 15 mm Hg
  18. Lower limb amputation
  19. Inferior vena cava thrombosis
  20. Patient under an exclusion period relative to participation to another clinical trial
  21. Patient under a legal protective measure
  22. Patient not affiliated to social security
  23. lac of patient/representative consent
  24. Pregnancy
  25. Breast feeding
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Personalized tidal volumePersonalized ventilationVentilation with tidal volume aiming to minimize cardiopulmonary interactions as assessed by pulse pressure variation
Standardized tidal volumePersonalized ventilationVentilation with tidal volume 6 ml/kg
Personalized tidal volumeStandardized ventilationVentilation with tidal volume aiming to minimize cardiopulmonary interactions as assessed by pulse pressure variation
Standardized tidal volumeStandardized ventilationVentilation with tidal volume 6 ml/kg
Primary Outcome Measures
NameTimeMethod
Tidal hyperinflation5 minutes - This endpoint will be assessed 5 minutes after ventilatory adjustment

Difference between hyperinflated volume in computed tomography images acquired at end-inspiration (defined by the volume of voxels with CT-number \< -900) and hyperinflated volume in computed tomography images acquired at end-expiration (defined by the volume of voxels with CT-number \< -900). This difference will be standardized to predicted body weight using the formula of the ARMA trial.

Secondary Outcome Measures
NameTimeMethod
Tidal volume5 hours - This endpoint will be assessed through study completion (approximately 4-5 hours after study inclusion)

Standardized versus personalized tidal volume

Trial Locations

Locations (1)

Hospices Civils de Lyon - Hôpital de la Croix Rousse - Service de Médecine Intensive Réanimation

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath